Skip to main navigation Skip to search Skip to main content

Developing a Novel Class of ERK5 Inhibitors for the Treatment of Triple-Negative Breast Cancer.

Details

Short titleR:KCD FINK3
StatusFinished
Effective start/end date1/09/18 → 31/10/21

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.